Novel N-substituted indole hydrazones as potential antiplatelet agents: synthesis, biological evaluations, and molecular docking studies
Background and purpose: Antiplatelet agents can diminish the chance of coronary heart diseases due to the prevention of unusual clotting in the arteries by inhibiting platelet aggregation and avoiding the formation of a blood clot. This mechanism can help to prevent ischemic stroke likewise. To impr...
Guardado en:
Autores principales: | Navid Tavili, Shaya Mokhtari, Hafezeh Salehabadi, Marjan Esfahanizadeh, Shohreh Mohebbi |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Wolters Kluwer Medknow Publications
2022
|
Materias: | |
Acceso en línea: | https://doaj.org/article/4ac94315828a4821975b569668718b3e |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Strategic approach to developing a self-microemulsifying drug delivery system to enhance antiplatelet activity and bioavailability of ticagrelor
por: Na YG, et al.
Publicado: (2019) -
ANTIPLATELET AGENTS IN THE TREATMENT AND SECONDARY PREVENTION OF ISCHEMIC STROKE (REVIEW OF LITERATURE)
por: E. Y. Kitaeva, et al.
Publicado: (2017) -
INDOLE DERIVATIVES AS POTENTIAL ANTICANCER AGENTS: A REVIEW
por: Sachdeva,Harshita, et al.
Publicado: (2020) -
Response to antiplatelet therapy in patients undergoing invasive treatment due to acute coronary syndrome complicated by cardiogenic shock
por: Wiktor Kuliczkowski, et al.
Publicado: (2020) -
Early Surgery with Neuraxial Anaesthesia in Patients on Chronic Antiplatelet Therapy with a Proximal Femur Fracture: Multicentric Randomised Clinical Trial
por: Rafael Anaya, et al.
Publicado: (2021)